publication date: Jun. 23, 2017

Douglas Lowy to remain deputy director of NCI as Sharpless takes over

By Matthew Bin Han Ong

NCI Acting Director Douglas Lowy will continue to serve as deputy director of the institute after Norman “Ned” Sharpless, director of the UNC Lineberger Comprehensive Cancer Center and the Wellcome Distinguished Professor in Cancer Research, is sworn in as the next NCI director.

Sharpless’s appointment was announced June 9. It is not publicly known when Sharpless will be starting in his new role.

“He has been successful at everything that he has done in his professional career, and there is every reason to believe that he will be highly successful as the next NCI director,” Lowy said June 20 at a joint meeting of the Board of Scientific Advisors and the National Cancer Advisory Board. “We are looking forward to working really closely together to make sure that we do right by all of you.”

Congressional appropriators are unlikely to cut the NIH budget over the next few years, Lowy said.

“Both Chairman [Tom] Cole [(R-OK)] and Chairman [Roy] Blunt [(R-MO)] made an oral commitment to continue to provide sustained increases to the NIH over the next few years,” Lowy said.

At a Senate appropriations hearing June 22, members of Congress vowed to resist President Donald Trump’s … Continue reading Douglas Lowy to remain deputy director of NCI as Sharpless takes over

To access this members-only content, please log in.
If you're not a subscriber why not join today?
If you believe you should be able to view this area but cannot log in, then please contact us and we will try to rectify this issue as soon as possible.
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2017 The Cancer Letter Inc.